Cargando...
Natalizumab treatment reduces L-selectin (CD62L) in CD4(+) T cells
BACKGROUND: The purpose of this research was to validate the low expression of L-selectin (CD62L) in natalizumab (NTZ)-treated patients. CD62L is involved in rolling and transmigration of leukocyte cells. A correlation between CD62LCD4(+) T cells low expression and progressive multifocal leukoenceph...
Guardado en:
| Publicado en: | J Neuroinflammation |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4532246/ https://ncbi.nlm.nih.gov/pubmed/26259673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-015-0365-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|